AI assistant
Dare Bioscience, Inc. — Director's Dealing 2014
Apr 10, 2014
34825_dirs_2014-04-10_3f5b0338-d144-4179-bf0b-d8e28e36ab66.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2014-04-10
Reporting Person: Garmey Edward Graeme (Sr. VP, Chief Medical Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6893 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $3.34 | 2021-06-08 | Common Stock (27572) | Direct | |
| Stock Option (right to buy) | $3.77 | 2022-01-24 | Common Stock (19300) | Direct | |
| Stock Option (right to buy) | $3.92 | 2022-12-18 | Common Stock (12628) | Direct | |
| Stock Option (right to buy) | $10.59 | 2024-01-09 | Common Stock (13786) | Direct |
Footnotes
F1: Reflects a 1-for-14.5074 reverse stock split effected on March 31, 2014.
F2: This option was granted on June 9, 2011. This option vested as to 25% of the underlying shares on May 2, 2012, and vests as to an additional 2.08333% of the shares monthly thereafter through May 2, 2015. The Reporting Person exercised the option in part on March 21, 2014.
F3: This option was granted on January 25, 2012. This option vested as to 25% of the underlying shares on December 31, 2012 and vests as to an additional 2.08333% of the shares monthly thereafter through December 31, 2015.
F4: This option was granted on December 19, 2012. The option vested as to 25% of the underlying shares on December 31, 2013 and vests as to an additional 2.08333% of the shares monthly thereafter through December 31, 2016.
F5: This option was granted on January 10, 2014. The shares subject to this option vest in 48 equal monthly installments from and after December 31, 2013 through December 31, 2017.